Literature DB >> 17485377

Dendritic cells in autoimmune diseases and neuroinflammatory disorders.

Sharron L Manuel1, Saifur Rahman, Brian Wigdahl, Zafar K Khan, Pooja Jain.   

Abstract

Dendritic cells are the most potent antigen presenting cells and have long been recognized as key regulators of the immune system, linking both stimulatory and inhibitory components of normal immunity. While DCs are fully characterized with respect to primary and secondary immune responses, their unique role in coordinating central and peripheral tolerance is just emerging. It is increasingly evident that the failure of DCs ability to maintain tolerance can lead to autoimmune and/or inflammatory diseases. However, existing literature highlighting participation of DCs in several autoimmune phenomena is scattered and remains underappreciated. This review is a comprehensive account of current knowledge characterizing the role of DCs in various autoimmune diseases including psoriasis, rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome, and diabetes. Additionally, it provides a rare description of DCs participation in various neuroinflammatory disorders including multiple sclerosis, HAM/TSP, Alzheimer disease and prion-associated diseases. Finally, a detailed description of the possible mechanisms of DC involvement in regulating immune response towards self versus non-self is discussed. Overall, the goal of this review is to establish DCs in the interface of tolerance and autoimmunity and generate a global interest in this field in order to exploit DC potential for the therapy of inflammatory diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17485377     DOI: 10.2741/2390

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions.

Authors:  Rashida Ginwala; Emily McTish; Chander Raman; Narendra Singh; Mitzi Nagarkatti; Prakash Nagarkatti; Divya Sagar; Pooja Jain; Zafar K Khan
Journal:  J Neuroimmune Pharmacol       Date:  2015-06-04       Impact factor: 4.147

Review 2.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

3.  Critical immunological pathways are downregulated in APECED patient dendritic cells.

Authors:  Nora Pöntynen; Mari Strengell; Niko Sillanpää; Juha Saharinen; Ismo Ulmanen; Ilkka Julkunen; Leena Peltonen
Journal:  J Mol Med (Berl)       Date:  2008-07-04       Impact factor: 4.599

4.  Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

5.  Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases.

Authors:  Rashida Ginwala; Raina Bhavsar; Patrick Moore; Mariana Bernui; Narendra Singh; Frank Bearoff; Mitzi Nagarkatti; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-30       Impact factor: 7.285

6.  Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells.

Authors:  Yaru Shi; Zhenlong Li; Ran Chen; Jiang Zhang; Xuefei Hu; Cong He; Qiong Su; Hongdou Ma; Hua Ren; Min Qian; Shufang Cui; Wenzheng Jiang
Journal:  Oncotarget       Date:  2017-08-24

Review 7.  Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.

Authors:  Tania H Mulherkar; Daniel Joseph Gómez; Grace Sandel; Pooja Jain
Journal:  Viruses       Date:  2022-09-14       Impact factor: 5.818

Review 8.  Gender and sex hormones in multiple sclerosis pathology and therapy.

Authors:  Arnaud Nicot
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  PPAR-gamma: Therapeutic Potential for Multiple Sclerosis.

Authors:  Paul D Drew; Jihong Xu; Michael K Racke
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.